Figure 9 is a forest plot that shows results of analysis of alpha-2-delta ligands for the outcome of: IRLS responders (defined as those with greater than or equal to 50% reduction in IRLS scale scores from baseline. Results of the analysis are described in the report text.

Figure 9Efficacy outcomes for treatment with alpha-2-delta ligands: IRLS responders (≥50% scale score reduction)

A-2-DL = Alpha-2-delta ligands; CI = confidence interval; IRLS = International Restless Legs Syndrome Study Group Rating Scale; M-H = Mantel Haenszel (statistical method)

From: Results

Cover of Treatment for Restless Legs Syndrome
Treatment for Restless Legs Syndrome [Internet].
Comparative Effectiveness Reviews, No. 86.
Wilt TJ, MacDonald R, Ouellette J, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.